458 related articles for article (PubMed ID: 19148354)
21. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
22. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
Silberhumer GR; Pokorny H; Hetz H; Herkner H; Rasoul-Rockenschaub S; Soliman T; Wekerle T; Berlakovich GA; Steininger R; Muehlbacher F
Transplantation; 2007 Mar; 83(5):588-92. PubMed ID: 17353779
[TBL] [Abstract][Full Text] [Related]
23. Pretransplant model to predict posttransplant survival in liver transplant patients.
Ghobrial RM; Gornbein J; Steadman R; Danino N; Markmann JF; Holt C; Anselmo D; Amersi F; Chen P; Farmer DG; Han S; Derazo F; Saab S; Goldstein LI; McDiarmid SV; Busuttil RW
Ann Surg; 2002 Sep; 236(3):315-22; discussion 322-3. PubMed ID: 12192318
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.
Li C; Wen TF; Yan LN; Li B; Yang JY; Xu MQ; Wang WT; Wei YG
Ann Hepatol; 2012; 11(4):471-7. PubMed ID: 22700628
[TBL] [Abstract][Full Text] [Related]
25. Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.
Kaplan DE; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Knott A; Mehta R; Pedrosa M; Pocha C; Valderrama A; Taddei T;
Dig Dis Sci; 2016 Nov; 61(11):3309-3320. PubMed ID: 27405990
[TBL] [Abstract][Full Text] [Related]
26. Hyponatremia and mortality among patients on the liver-transplant waiting list.
Kim WR; Biggins SW; Kremers WK; Wiesner RH; Kamath PS; Benson JT; Edwards E; Therneau TM
N Engl J Med; 2008 Sep; 359(10):1018-26. PubMed ID: 18768945
[TBL] [Abstract][Full Text] [Related]
27. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
Chawla YK; Kashinath RC; Duseja A; Dhiman RK
J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
[TBL] [Abstract][Full Text] [Related]
28. Serum sodium and survival benefit of liver transplantation.
Sharma P; Schaubel DE; Goodrich NP; Merion RM
Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
[TBL] [Abstract][Full Text] [Related]
29. Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation.
Yang M; Khan AR; Lu D; Wei X; Shu W; Xu C; Pan B; Zhou Z; Wang R; Wei Q; Cen B; Cai J; Zheng S; Xu X
Front Med (Lausanne); 2022; 9():772048. PubMed ID: 35308496
[TBL] [Abstract][Full Text] [Related]
30. MELD and other predictors of survival after liver transplantation.
Brandão A; Fuchs SC; Gleisner AL; Marroni C; Zanotelli ML; Cantisani G;
Clin Transplant; 2009; 23(2):220-7. PubMed ID: 19210688
[TBL] [Abstract][Full Text] [Related]
31. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
[TBL] [Abstract][Full Text] [Related]
33. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
[TBL] [Abstract][Full Text] [Related]
34. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
35. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
[TBL] [Abstract][Full Text] [Related]
36. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.
Xavier SA; Vilas-Boas R; Boal Carvalho P; Magalhães JT; Marinho CM; Cotter JB
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):652-658. PubMed ID: 29438135
[TBL] [Abstract][Full Text] [Related]
37. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
38. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
[TBL] [Abstract][Full Text] [Related]
39. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
[TBL] [Abstract][Full Text] [Related]
40. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
